BioVie Inc. Derivative Liability
BioVie Inc. (BIVI) had Derivative Liability of $7.29 thousand as of 2024-12-31, per its 10-Q filed 2025-02-11.
Financial Statements › Balance Sheet › Liabilities
us-gaap:DerivativeLiabilities · last filed 2025-02-11
- 2024-12-31: Derivative Liability $7.29K.
- 2024-09-30: Derivative Liability $1.25K.
- 2024-06-30: Derivative Liability $3.77K.
- 2024-03-31: Derivative Liability $20.70K.
| Period end | Derivative Liability |
|---|---|
| 2024-12-31 | $7.29K 10-Q · filed 2025-02-11 |
| 2024-09-30 | $1.25K 10-Q · filed 2024-11-13 |
| 2024-06-30 | $3.77K 10-Q · filed 2025-02-11 |
| 2024-03-31 | $20.70K 10-Q · filed 2024-05-14 |
| 2023-12-31 | $129.71K 10-Q · filed 2024-02-13 |
| 2023-09-30 | $1.11M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $1.82M 10-K · filed 2024-09-30 |
| 2023-03-31 | $4.54M 10-Q · filed 2023-05-12 |
| 2022-12-31 | $4.17M 10-Q · filed 2023-02-10 |
| 2022-09-30 | $949.10K 10-Q · filed 2022-11-04 |
| 2022-06-30 | $382.56K 10-K · filed 2023-08-16 |
| 2022-03-31 | $2.50M 10-Q · filed 2022-05-11 |
| 2021-12-31 | $2.11M 10-Q · filed 2022-02-08 |
| 2020-06-30 | $21.41M 10-K · filed 2021-08-30 |
| 2020-03-31 | $2.88M 10-Q · filed 2020-05-13 |
| 2019-12-31 | $3.25M 10-Q · filed 2020-02-13 |
| 2019-09-30 | $10.64M 10-Q · filed 2019-11-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |